LENZ Insider Trading Activity and SEC Form 4 Filings
LENZ insider trading summary
Over the past 12 months, insiders at LENZ Therapeutics, Inc. (LENZ) reported 14 sales worth $36.8M by 5 insiders and 3 open-market purchases worth $289K by 2 insiders on SEC Form 4. Net insider selling was $36.5M.
Latest LENZ insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 29, 2026 | Ra Capital Management, L.P. | Insider | Sell | $360K (107,170 @ $3.36) |
| Oct 29, 2026 | Rajeev M. Shah | 10% Owner | Sell | $7.3M (2,159,516 @ $3.36) |
| Oct 29, 2026 | RA Capital Healthcare Fund LP | 10% Owner | Sell | $1.5M (451,998 @ $3.36) |
| Oct 29, 2026 | Rajeev M. Shah | 10% Owner | Sell | $1.5M (451,998 @ $3.36) |
| Oct 29, 2026 | RA Capital Healthcare Fund LP | 10% Owner | Sell | $7.3M (2,159,516 @ $3.36) |
| Oct 29, 2026 | Peter Kolchinsky | 10% Owner | Sell | $7.3M (2,159,516 @ $3.36) |
| Oct 29, 2026 | Ra Capital Management, L.P. | Insider | Sell | $7.3M (2,159,516 @ $3.36) |
| Oct 29, 2026 | Ra Capital Management, L.P. | Insider | Sell | $1.5M (451,998 @ $3.36) |
| Oct 29, 2026 | Peter Kolchinsky | 10% Owner | Sell | $1.5M (451,998 @ $3.36) |
| Oct 29, 2026 | RA Capital Healthcare Fund LP | 10% Owner | Sell | $360K (107,170 @ $3.36) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.